Evidence map›Paper›PMID 39572221›Full record

Trial reportThe European respiratory journal2025

Arousal threshold modifies the effect of CPAP on executive function among individuals with obstructive sleep apnoea.

Andrey V Zinchuk, Clete A Kushida, Alexander Walker, Andrew Wellman, Ali Azarbarzin, Raichel M Alex, Andrew W Varga, Scott A Sands, H Klar Yaggi

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The European respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00051363 (APPLES), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00051363 phase3completednot on this map

APPLES: Apnea Positive Pressure Long-Term Efficacy Study

TypeinterventionalSponsorStanford UniversityRan2002 to 2008Enrolled1,105ConditionsLung Diseases, Sleep Apnea Syndromes, SleepArmsActive CPAP, Sham CPAP
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Andrey V ZinchukDepartment of Medicine, Yale University School of Medicine, New Haven, CT, USA andrey.zinchuk@yale.edu.
Clete A KushidaDivision of Sleep Medicine, Department of Psychiatry and Behavioral Sciences, Stanford Hospital and Clinics, Stanford, CA, USA.
Alexander WalkerDepartment of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
Andrew WellmanDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Ali AzarbarzinDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Raichel M AlexDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Andrew W VargaMount Sinai Integrative Sleep Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID https://orcid.org/0000-0002-3668-3371
Scott A SandsDivision of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
H Klar YaggiDepartment of Medicine, Yale University School of Medicine, New Haven, CT, USA.

Funding

Project 5: Novel strategies to prevent opioid-induced hypoventilation during sleep and identification of underlying mechanismsP01HL149630 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CLIFFORD B SAPER · 2020 to 2026
$22.3M
Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL)R01AG080609 · NIA · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI OSORIO, RICARDO S, STONE, KATIE L · 2023 to 2024
$7.4M
Validation of a Phenotype Model to Predict Response to Alternative OSA TreatmentsR01HL102321 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WELLMAN, DAVID ANDREW · 2011 to 2025
$7.3M
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease: An Investigation of STN LFP Biomarkers In Sleep Dysregulation and RepairUH3NS113769 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ABOSCH, AVIVA, HALPERN, CASEY HARRISON · 2020 to 2025
$5.2M
Determination of the site of pharyngeal collapse in Obstructive Sleep Apnea patients from snoring soundsR01HL128658 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WELLMAN, DAVID ANDREW · 2016 to 2025
$4.3M
Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep ApneaR01HL158765 · NHLBI · UNIVERSITY OF WASHINGTON · PI KWON, YOUNGHOON · 2021 to 2025
$3.5M
A Novel Pharmacological Therapy for Obstructive Sleep ApneaR01HL146697 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SANDS, SCOTT A · 2019 to 2023
$3.4M
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep ApneaR01HL153874 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AZARBARZIN, ALI · 2020 to 2024
$3.3M
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)UG3HL169648 · NHLBI · STANFORD UNIVERSITY · PI HSING, ANN, KUSHIDA, CLETE A · 2023 to 2024
$1.2M
Novel physiologiC prEdictors of Positive Airway Pressure effectiveness: NICE-PAP study.K23HL159259 · NHLBI · YALE UNIVERSITY · PI ZINCHUK, ANDREY · 2021 to 2025
$843k
Mentoring in Sleep Research and Sleep Interventions in Heart Disease, and StrokeK24HL132093 · NHLBI · YALE UNIVERSITY · PI YAGGI, HENRY KLAR · 2016 to 2020
$336k
Novel physiologically-driven phenotypes for the prognosis of cardiovascular outcomes in sleep apnea: Toward precision medicine in sleep healthR21HL161766 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AZARBARZIN, ALI · 2022 to 2023
$279k
NHLBI NIH HHS K23 HL159259NHLBI NIH HHS K24 HL132093NHLBI NIH HHS L30 HL143623NHLBI NIH HHS P01 HL149630NHLBI NIH HHS R01 HL102321NHLBI NIH HHS R01 HL128658NHLBI NIH HHS R01 HL146697NHLBI NIH HHS R01 HL153874NHLBI NIH HHS R01 HL158765NHLBI NIH HHS R21 HL161766NHLBI NIH HHS UG3 HL169648NIA NIH HHS R01 AG080609NINDS NIH HHS UH3 NS113769
6 · The paper itself

Abstract

backgroundObstructive sleep apnoea (OSA) is associated with neurocognitive dysfunction. However, randomised trials evaluating the effects of continuous positive airway pressure (CPAP) on neurocognition in those without dementia do not show a benefit. We thus aimed to assess whether arousal threshold (ArTH) modifies the effect of CPAP on neurocognitive function.

methodsWe performed a secondary analysis of a randomised, sham-controlled trial (Apnea Positive Pressure Long-term Efficacy Study (APPLES); ClinicalTrials.gov: NCT00051363). ArTH was estimated from polysomnography using a translatable method. Neurocognitive outcomes included the Sustained Working Memory Test-Overall Mid-Day (SWMT-OMD) score (executive function, primary outcome), with the Pathfinder Number Test total time (attention) and Buschke Selective Reminding Test sum recall (learning and memory) as secondary outcomes. Generalised linear modelling assessed whether the effect of CPAP was modified by baseline ArTH (treatment×ArTH interaction). 833 participants with OSA (apnoea-hypopnoea index ≥10 events·h

resultsFor executive function, the effect of CPAP treatment was modified by ArTH (p

conclusionIn OSA, a higher ArTH is associated with greater improvements in executive function following CPAP therapy.

Indexed as

ArousalContinuous Positive Airway PressureExecutive FunctionSleep Apnea, ObstructiveAdultAgedFemaleHumansMaleMemory, Short-TermMiddle AgedPolysomnographyTreatment Outcome

Identifiers

PMID39572221
PMCPMC12301966

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.